Welcome to our dedicated page for Adtalem Global Ed SEC filings (Ticker: ATGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Adtalem Global Education Inc. (NYSE: ATGE), a for-profit operator of colleges, universities, and professional schools with a strong emphasis on healthcare education. As a New York Stock Exchange–listed company, Adtalem files periodic and current reports that offer detailed information on its operations, financial condition, governance, and shareholder-related actions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q contain segment-level data for the Chamberlain, Walden, and Medical and Veterinary segments, along with discussions of enrollment, revenue, operating income, and risk factors. These filings help readers understand how institutions such as Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine contribute to Adtalem’s overall results.
Current reports on Form 8-K document specific material events. Recent 8-K filings have covered the announcement of a new share repurchase authorization of up to $750 million and the completion of a prior $150 million repurchase program, the release of quarterly financial results, the retirement of the president of Chamberlain University, and the adoption of a Rule 10b5-1 trading plan by the company’s chief executive officer. Another 8-K reports the results of Adtalem’s annual meeting of shareholders, including director elections, auditor ratification, and an advisory vote on executive compensation.
Investors can also review Forms 4 and related insider trading disclosures referenced in company communications, which report transactions executed under trading plans such as the disclosed Rule 10b5-1 plan. Together, these filings provide a regulatory record of Adtalem’s financial performance, capital allocation decisions, governance matters, and insider activity.
Stock Titan’s platform enhances these filings with AI-powered summaries that highlight key points from lengthy documents, making it easier to identify segment performance, capital allocation actions, and governance changes without reading every page. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 filings for ATGE are available promptly, while AI-generated explanations help readers interpret complex disclosures in accessible language.
Adtalem Global Education Inc.'s Chairman and CEO reported a charitable stock gift. On 12/10/2025, he transferred 5,332 shares of Adtalem common stock as a gift, with a reported transaction price of $0. Following this donation, he beneficially owned 445,198 shares directly. This filing is a routine insider ownership update and does not reflect a market sale.
Adtalem Global Education reported final results from its Annual Meeting of Shareholders held on November 12, 2025. Shareholders voted on director nominees and other proposals, with detailed tallies disclosed.
For director nominees, “For” votes ranged from 30,915,164 (Stephen W. Beard) to 31,742,972 (Kenneth J. Phelan). Each nominee’s “Against” votes were under 820,000, with broker non‑votes of 1,443,088 recorded for all director items.
Additional proposals received the following totals: 32,536,515 For, 627,124 Against, and 78,017 Abstain; and 27,143,411 For, 4,326,428 Against, 328,729 Abstain, with 1,443,088 broker non‑votes.
Adtalem Global Education (ATGE) — Form 4 insider activity: A director was granted 1,445 restricted stock units on 11/12/2025. The award size was based on dividing the director compensation by $96.86, the ATGE closing price on that date, and these units vest 100% one year from the grant. On 11/13/2025, 645 shares were withheld to satisfy tax obligations upon the vesting of previously awarded RSUs. Following these transactions, the director beneficially owns 44,251 common shares directly.
Adtalem Global Education (ATGE) reported insider activity by a director. On November 12, 2025, the director acquired 1,445 restricted stock units (RSUs) at a reference price of $96.86. These RSUs vest 100% one year after the grant date.
On November 13, 2025, 421 shares were withheld to satisfy tax obligations at $96.26 (Transaction Code F). Following these transactions, the director directly owns 2,584 shares.
Adtalem Global Education (ATGE) Form 4: Company officer (President, Adtalem Elevate) reported equity movements. On 11/12/2025, the insider received 1,673 restricted stock units, which convert one-for-one into common shares and vest in three equal installments beginning on November 12, 2026, recorded at $96.86. On 11/13/2025, 355 shares were withheld at $96.26 to satisfy taxes upon the vesting of previously awarded RSUs.
Following these transactions, the insider reports 24,134 shares beneficially owned, held directly.
Adtalem Global Education (ATGE) Form 4: the company’s Chief Financial Officer, Mr. Phelan, reported equity award activity. On 11/12/2025, 4,259 restricted stock units (RSUs) were acquired at a reported price of $96.86. These RSUs convert one-for-one into common shares and vest in three equal installments beginning on November 12, 2026.
On 11/13/2025, 623 shares were disposed of under code “F” at $96.26, representing shares withheld to satisfy tax obligations upon a prior RSU vesting. Following these transactions, the officer directly beneficially owns 65,806 common shares.
Adtalem Global Education (ATGE) reported insider activity via Form 4. On November 12, 2025, a director received 1,445 restricted stock units (RSUs), with the grant size determined using the $96.86 closing price. These RSUs vest 100% one year after the grant date.
On November 13, 2025, 392 shares were withheld to satisfy tax obligations related to previously granted RSUs at a price of $96.26. After the reported transactions, the director beneficially owned 19,836 shares, held directly.
Adtalem Global Education (ATGE) Form 4: Director Ms. O’Keefe was granted 1,445 restricted stock units representing common stock on 11/12/2025 at a reference price of $96.86. The award vests 100% on the one-year anniversary of the transaction date.
Following the reported grant, beneficial ownership stands at 16,597 shares, held directly. This is a routine director equity award intended to align compensation with shareholder interests.
Adtalem Global Education (ATGE) reported an insider equity award on Form 4. The Chief Corporate Affairs Officer acquired 2,226 shares of common stock on 11/12/2025 coded “A,” reflecting a grant of restricted stock units at a reference price of $96.86 per share.
The award consists of RSUs that convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026. Following the transaction, the reporting person beneficially owned 2,226 shares, held directly.
Adtalem Global Education (ATGE) Form 4: Lead Independent Director (and Director) reported equity transactions. On 11/12/2025, the reporting person acquired 1,445 shares of common stock in the form of restricted stock units (RSUs) at a reference value of $96.86 per unit, reflecting the closing price used to determine the award size. On 11/13/2025, 526 shares were disposed of to satisfy tax withholding upon vesting at $96.26 per share.
Following these transactions, the reporting person beneficially owns 101,364 shares, held directly. The RSUs vest 100% on the one-year anniversary of the grant date.